Read about the latest NIA Funding Opportunities (published in November 2021) by clicking on the links below:
- PAR-22-047: Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional)
- RFA-AG-23-004: Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed)
- RFA-AG-22-030: Resource Networks for Protein Polymorphisms in Alzheimer’s Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)
- RFA-AG-22-026: Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
Notices
- NOT-AG-21-062: Request for Information (RFI): Inviting comments and suggestions on the development of a healthy aging start-up challenge and bootcamp to foster diversity and accelerate innovation.
- NOT-AG-22-001: NIA Intervention Testing Program (ITP) Announces Annual Call for Compounds to Test for Anti-Aging Activity in Mice
